63例扩张型心肌病的长期随访分析  

Follow up analysis of forword prognosis in 63 patients with dilated cardiomyopathy

作　　者：李书义[1] 杨红亚[1] 李法祥[1] 

机构地区：[1]解放军第371中心医院老年科,河南新乡453000

出　　处：《临床心血管病杂志》2007年第7期494-495,共2页Journal of Clinical Cardiology

摘　　要：目的:评价扩张型心肌病的远期预后。方法:扩张型心肌病患者63例,给予强心、利尿、β受体阻滞剂、血管紧张素转化酶抑制剂及中药生脉(参麦)复方制剂治疗,定期随访,随访时间3～13年。随访项目包括:心功能改善情况、体力活动适应程度、院外服药治疗、再次入院次数,死亡,了解并登记死亡原因。结果:63例中随访3～5年16例,5～10年35例,10年以上12例,平均随访时间6.1年。随访期间死亡18例(病死率28.6%);存活45例,存活者患病时间2～15年,其中28例能从事一般正常劳动及工作(62.2%),生活可自理者10例(22.2%)。结论:由于治疗方案的改进,特别是中西医结合药物的应用,使扩张型心肌病患者的预后改善,平均存活时间延长,多数患者的生存质量提高。Objective： To evaluate the forword prognosis in patients with dilated cardiomyopathy, Method： There were 63 patients with dilated cardiomyopathy enrolled in the study. Drug therapy included., strengthening heart, diuresissing, expanding blood vessels, ACEI types, β-receptor blockers and traditional Chinese medicine compound such as Shengmai. The patients had been followed up 3-13 years since the first time they were hospitalized. Follow up items included： improvement of heart function, physical capacity,therapy by taking medicine outside hospital,tlmes of being hospitalized since the first time, finding out and registering the death cause if the patient died. Result： Among 63 cases, 16 cases were followed up 3-5 years,35 cases were followed up 5-10 years,12 cases were followed up more than 10 years, and the average time was 6.1 years. During the follow up 18 patients died（mortality rate 28.6%）, 45 survivals suffered from dilated cardiomyopathy between 2 and 15 years, and among them, 28 could take common physical labour and work （62.8%）, 10 could live by themselves（22.2%）. Conclusion：Forword prognosis of dilated cardiomyopathy patients could be improved by the combined therapy of Chinese and Western medicines.

关 键 词：心肌病 扩张型 预后 随访 

分 类 号：R542.2[医药卫生—心血管疾病]